Hodogaya Chemical Co., Ltd.

Hodogaya Chemical Co., Ltd.

4112.T
Hodogaya Chemical Co., Ltd.JP flagTokyo Stock Exchange
2,045.00
JPY
-41.00
- -
32.53BMarket Cap
Hodogaya Chemical Co., Ltd.
4112.T
(Tokyo Stock Exchange)

Recent

price

2,045.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
2,113.62
2,224.1
2,224.35
2,256.02
2,193.36
2,139.33
2,197.41
2,448.5
2,375.96
2,389.62
2,603.22
2,644.65
2,734.52
2,789.05
3,056.93
3,021.3
2,790.54
Revenue per Share
35.59
102.58
-5.69
-80.35
39.39
51.29
123.41
181.11
119.15
117.55
197.08
205.3
140.31
156.27
199.99
192.07
156.36
Basic EPS, GAAP
163.58
8.72
-72.12
7.84
153.02
120.92
155.92
202.37
22.78
98.06
193.73
276.72
-129.9
188.28
15.61
-15.97
188.39
Free Cash Flow per Basic Share
39.76
39.95
29.83
19.22
19.85
24.86
24.8
29.8
25.06
24.99
24.83
27.34
31.05
35.54
42.16
48.55
19.17
Dividend per Share
1,019.45
1,082.09
1,046.34
946.1
966.17
992.69
383.07
1,242.82
1,337
1,429.31
1,599.56
1,773.18
1,881.42
2,007.36
2,162.41
2,304.65
2,008.44
Book Value per Share
1,639.51
1,641.28
1,728.67
1,746.3
1,968.57
1,945.1
2,128.21
2,258.66
2,322.74
2,333.38
2,742.73
3,010.22
3,134.06
3,584.4
3,622.22
3,949.64
3,586.33
Tangible Book Value per Share
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
Basic Weighted Avg Shares
33,440
35,188
35,191
35,687
34,688
33,826
34,739
38,693
37,548
37,771
41,199
41,879
43,324
44,261
48,578
48,040
44,261
Sales/Revenue/Turnover
11.77
9.51
6.89
4.3
6.03
6.42
6.14
10.1
8.07
7.7
13.23
15.34
8.55
8.94
10.05
7.74
8.94
Operating Margin (%)
1,731
2,005
2,424
2,235
2,118
2,358
1,568
1,433
1,394
1,492
1,506
1,672
1,942
2,399
3,017
3,414
2,399
Depreciation Expense
563
1,623
-90
-1,271
623
811
1,951
2,862
1,883
1,858
3,119
3,251
2,223
2,480
3,178
3,054
2,480
Net Income, GAAP
17.01
2.58
54.53
- -
2.46
9.82
12.62
4.72
21.96
18.34
16.35
23.22
25.31
20.37
5.26
- -
20.37
Effective Tax Rate (%)
1.68
4.61
-0.26
-3.56
1.8
2.4
5.62
7.4
5.01
4.92
7.57
7.76
5.13
5.6
6.54
6.36
5.6
Profit Margin (%)
9,184
9,498
8,577
8,392
11,330
11,255
14,481
13,621
15,581
15,356
18,313
22,526
23,624
23,905
22,501
23,581
23,905
Working Capital
4,350
5,300
4,878
5,817
6,297
4,467
5,376
4,040
5,164
4,698
3,614
3,892
5,655
4,639
3,266
4,351
4,639
LT Debt
26,971
28,184
29,236
29,151
32,107
31,056
33,857
35,868
36,858
37,039
43,652
47,911
49,895
57,441
58,528
63,612
57,441
Total Equity
8.48
8.44
2.69
- -
4.72
4.49
4.35
8.56
5.28
5.19
9.26
9.06
4.71
4.85
6.78
- -
4.85
Return on Invested Capital (%)
2.65
5.39
-1.73
- -
1.87
3.85
9.28
9.56
4.8
4.13
4.22
4.4
2.89
2.58
3.55
- -
2.58
Return on Capital (%)
3.48
9.76
-0.53
-8.06
4.12
5.24
17.94
22.28
9.24
8.5
13.02
12.18
7.68
8.04
9.6
8.6
8.04
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'24
Dec'24
Mar'24
ST Debt
5,179
5,083
5,172
LT Borrowings
4,840
4,644
4,346
LT Finance Leases
- -
- -
293
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
16
16
16
Market Capitalization
25,219
29,502
28,946

Working Capital

FRC

in mil. unless spec.
Sep'24
Dec'24
Mar'24
Total Current Assets
38,465
37,814
38,675
Cash, Cash Equivalents & STI
14,549
13,249
12,965
Accounts Receivable, Net
10,664
11,212
12,265
Inventories
12,249
12,405
12,634
Total Current Liabilities
14,149
14,037
14,770
Payables & Accruals
- -
- -
- -
ST Debt
5,179
5,083
5,172
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.57%
7.92%
8.69%
Free Cash Flow
-24.51%
-128.67%
-202.42%
Net Income, GAAP
22.8%
1.68%
-3.9%
Sales/Revenue/Turnover
3.67%
3.18%
-1.11%
Total Cash Common Dividend
7.57%
14.49%
15.22%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
10,041
10,410
11,191
12,619
44,261
2025
- -
- -
- -
- -
48,578
2026
- -
- -
- -
- -
48,040

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
23.26
- -
- -
- -
156.27
2025
- -
- -
- -
- -
199.99
2026
- -
- -
- -
- -
192.07

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
35.54
2025
- -
- -
- -
- -
42.16
2026
- -
- -
- -
- -
48.55
Business
Hodogaya Chemical Co., Ltd., founded in 1916 and headquartered at Shiodome Sumitomo Bldg in Tokyo, Japan, manufactures and sells specialty chemicals across five core segments including functional colorants such as OLED emitting, transport, and capping layer materials, dyes for color filters, copier toners, aluminum coloring, stationery, hair color treatment, and natural dyes for food and industrial use, as well as perovskite solar cell and semiconductor resist materials; specialty polymers encompassing urethane materials like PTG, BIO-PTG, and PTG-SOFTENA, phosgene derivatives serving as intermediates for pharmaceuticals, functional polymers, and electronic materials, adhesives, release agents, and urethane-based waterproof materials for construction and civil engineering with associated waterproofing services; basic chemicals featuring hydrogen peroxide, sodium percarbonate for bleaching and detergents, peracetic acid as disinfectants and food additives, and industrial chemicals; agro-science products comprising herbicides, pesticides, fungicides, growth control agents for croplands, golf courses, and green areas, plus agricultural materials like oxygen supply agents; and logistics services offering warehousing for hazardous substances, chemicals, and general goods, consigned freight forwarding, and ISO tank container storage. The company operates plants in Yokohama, Koriyama, and Nanyo in Japan, a research center in Tsukuba, and maintains subsidiaries and facilities including SFC Co., Ltd., Hodogaya Chemical Korea Co., Ltd., and REXCEL Co., Ltd. in South Korea, Hodogaya Chemical (U.S.A.), Inc. in New York, Hodogaya (Shanghai) Trading Co., Ltd. in China, and Hodogaya Chemical Europe GmbH in Germany, serving global markets in electronics, life sciences, construction, agriculture, and logistics. Recent developments include consolidating REXCEL Co., Ltd. into the group in April 2023 to bolster electronic materials production with advanced purification technology, launching the second plant at REXCEL's Chungju campus in April 2024 and constructing a new plant at the Eumseong campus for September 2024 operations, establishing SFC's BioPark in November 2023 for biopharmaceutical expansion into oligonucleotides and PCR diagnostic kits, creating the Organic & Optical Device Materials Division and Advanced Device Materials Department in April 2023 to pursue semiconductor resist and perovskite solar cell materials, completing initial expansion of oxygen supply materials production in the agro-science segment, and forming the Korea Business Strategy Office in July 2023 under direct presidential control to accelerate investments in South Korean operations, which now represent growing importance amid the Mid-term Management Plan SPEED 25/30 targeting enhanced ROE and sustainable growth by FY2030.